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Abstract
Background: Basic helix-loop-helix E proteins are transcription factors that play crucial roles in
T cell development by controlling thymocyte proliferation, differentiation and survival. E protein
functions can be repressed by their naturally occurring inhibitors, Id proteins (Id1-4). Transgenic
expression of Id1 blocks T cell development and causes massive apoptosis of developing
thymocytes. However, the underlying mechanisms are not entirely understood due to relatively
little knowledge of the target genes regulated by E proteins.
Results: We designed a unique strategy to search for genes directly controlled by E proteins and
found RORγt to be a top candidate. Using microarray analyses and reverse-transcriptase PCR
assays, we showed that Id1 expression diminished RORγt mRNA levels in T cell lines and primary
thymocytes while induction of E protein activity restored RORγt expression. E proteins were found
to specifically bind to the promoter region of RORγt, suggesting their role in activating
transcription of the gene. Functional significance of E protein-controlled RORγt expression was
established based on the finding that RORγt rescued apoptosis caused by Id1 overexpression.
Furthermore, expression of RORγt prevented Id1-induced p38 MAP kinase hyper-activation.
Conclusion: These results suggest that E protein-dependent RORγt gene expression aids the
survival of developing thymocytes, which provides a possible explanation for the massive apoptosis
found in Id1 transgenic mice.
Background
T lymphocytes differentiate in the thymus from multipo-
tent progenitors derived from the bone marrow. The
developmental program can be monitored by expression
of CD4 and CD8 surface markers, and progenitors
advance sequentially through the double negative (DN),
double positive (DP) and CD4 or CD8 single positive
(SP) stages [1,2]. Within the DN stage, development can
be sub-divided into 4 phases based on CD44 and CD25
expression [3,4]. Elaborate selection schemes ensure each
developing thymocyte expresses a functional T cell recep-
tor with appropriate avidity to foreign peptides presented
by self MHC while simultaneously maintaining tolerance
to self-antigens [5,6]. These selection processes involve
precise regulation of cell proliferation and apoptosis. Ulti-
mately, mechanisms are in place to ensure desirable
mature thymocytes survive and exit the thymus.
T cell development is largely driven by the function of var-
ious transcription factors and signaling events originating
from cytokine and T cell receptors. One group of tran-
scription factors involved in this process is the basic helix-
loop-helix (bHLH) family of proteins. E47 and E12 (each
encoded by the E2A gene), as well as HEB, are the pre-
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dominant bHLH proteins expressed in T cells, which are
collectively called E proteins [7,8]. Disruption of either
the E2A or HEB gene results in partial impairment of T cell
development at several critical checkpoints, such as selec-
tion processes involving pre-TCR and TCR [9-12]. The
function of E proteins can be blocked by their natural
inhibitors, Id proteins [13,14]. While the Id3 gene is
turned on following pre-TCR and TCR signaling [15,16],
the Id1 gene has recently been found to be specifically
activated during T cell negative selection [17], a process
that eliminates self-reacting T cells. This finding suggests a
physiological role for Id1 in triggering T cell death. Con-
sistently, T cell specific overexpression of Id1 in transgenic
mice diminishes the function of both E2A and HEB pro-
teins and results in a severe developmental arrest at the
earliest progenitor stages that is also accompanied by mas-
sive apoptosis [18-20]. Despite the dramatic phenotypic
changes resulting from E protein deficiency, the underly-
ing molecular mechanisms remain poorly understood.
Current knowledge about genes directly controlled by E
proteins cannot satisfactorily explain the phenotypes of
various mutant mouse strains defective in E protein func-
tion. For example, diminished expression of pre-T cell
receptor α or impaired TCR rearrangement in the absence
of E protein function would have resulted in developmen-
tal arrests at the DN3 stage instead of the DN1 to DN2
transition seen in Id1 transgenic or E2A deficient mice
[21,22]. Therefore, intense efforts have been devoted to
identifying new targets of E proteins. However, it has been
a challenge to distinguish between those genes directly
controlled by E proteins and those that reflect secondary
changes in E protein activities. Here, we report a strategy
that is designed to increase the probability of obtaining
direct targets of E proteins using microarray analyses.
One of the best candidates we obtained using this strategy
was the gene encoding RORγ transcription factors. In T
lineage cells, an alternative form, RORγt, is expressed from
an internal promoter and is believed to play a role in the
survival of double positive thymocytes [23]. RORγ defi-
cient mice exhibit reduced thymic cellularity and excessive
apoptosis, which is reminiscent of the phenotype of Id1
transgenic mice [24,25]. RORγt is also thought to inhibit
the proliferation of DP thymocytes, which may be part of
an integral mechanism balancing thymocyte proliferation
and survival following pre-TCR signaling [26]. Interest-
ingly, E protein function is also regulated by pre-TCR sig-
naling through expression of the Id3 gene, which is driven
by Egr transcription factors [15]. Therefore, it has been
proposed that the interplay between RORγt, Egr3 and E
proteins plays an important role at the transition from DN
to DP stages [26]. We have shown here that inhibition of
E protein function by Id1 leads to apoptosis in a DP lym-
phoma cell line, and co-expression of Id1 with RORγt res-
cued cell death in these cells. These results provide a
possible explanation for the massive apoptosis occurring
in DP thymocytes in Id1 transgenic mice, namely, reduced
RORγt expression and diminished thymocyte survival due
to inhibition of E protein function.
Results
Alterations in gene expression by loss or gain of E protein 
function
To understand the molecular mechanisms by which E
proteins control T cell development, we sought for genes
whose expression is directly regulated by E2A transcrip-
tion factors using DNA microarray analyses. Our past
attempts to compare gene expression profiles in defined
thymocyte subsets isolated from wild-type and Id1 trans-
genic mice were not fruitful due to indirect influences on
gene expression created by the abnormal cellular environ-
ment in which Id1 transgenic thymocytes develop. For
example, high levels of TNFα and IFNγ in Id1 transgenic
thymuses resulted in changes in genes induced by these
cytokines even though E2A is unlikely to directly regulate
these genes (Yang and Sun, data not shown) [27]. There-
fore, we made use of a CD4 and CD8 double positive T
lymphoma cell line, 16610D9, which expresses high lev-
els of E2A proteins.
To increase the probability of identifying direct targets of
E2A, we designed a strategy to single out genes whose
expression is inhibited by Id1 and then turned back on
immediately after inducible E2A expression (Fig. 1). In
this experiment, 16610D9 cells were transduced with ret-
roviruses expressing Id1 or E47-ER proteins individually,
or together. E47-ER is a fusion protein between the full-
length E47 and a modified hormone-binding domain of
human estrogen receptor, which has selectively higher
affinity to tamoxifen than estrogen [28]. Induction with
tamoxifen releases E47-ER from the cytoplasm to the
nucleus and allows it to bind DNA. YFP and GFP were also
expressed from an internal ribosome entry site along with
Id1 and E47-ER, respectively. As negative controls, cells
were transduced with empty vectors that expressed only
GFP. To ensure a clear separation of cells expressing GFP
or YFP, as well as both, we conducted control experiments
to establish sorting conditions. As shown in Fig. 1B, cells
individually transduced with YFP and GFP expressing vec-
tor control viruses were clearly separated when they were
mixed. In contrast, when cells were co-infected with both
types of viruses, three populations which were single or
double positive for YFP or GFP, were easily distinguisha-
ble. Transduced cells were then sorted based on fluores-
cence from GFP and YFP. These cells were treated with 4-
hydroxyl-tamoxifen (4-OHT) or vehicle control for 1
hour. Cells were then harvested for isolation of total RNA
to be used in microarray studies and for preparation of
nuclear extracts. Electrophoretic mobility shift assays
shown in Fig. 1C demonstrated that the E-box bindingBMC Immunology 2008, 9:20 http://www.biomedcentral.com/1471-2172/9/20
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Alteration of E2A activity in 16610D9 cells Figure 1
Alteration of E2A activity in 16610D9 cells. (A) Scheme of retroviral infection and treatment of cells used for microarray 
analyses. Retroviral constructs are diagrammed with key components labeled. (B) FACS analysis of 16610D9 cells infected with 
YFP and GFP expressing retroviruses, individually or together. The left panel shows the profile of a mixture of cells infected 
with either YFP or GFP expressing viruses. The right panel represents the profile of cells co-infected with both types of viruses. 
(C) Electrophoretic mobility shift assays of E2A DNA binding activity in indicated cells with (+) or without (-) 4-OHT treat-
ment. Oct1 binding activities were used as controls for the amount and quality of nuclear extracts. Experimental procedures 
are as described [19].
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activity of E proteins was inhibited by expression of Id1 in
the absence or presence of 4-OHT (lane1 versus 4 and 5).
In cells transduced with both Id1 and E47-ER expressing
retroviruses, E box binding activities were reduced in cells
without 4-OHT treatment but markedly increased upon
induction of E47-ER with 4-OHT (lanes 2 and 3). Oct1
binding activities served as controls for the amount and
quality of nuclear extracts. These results suggest that E pro-
tein functions can be manipulated by expression of Id1
and E47-ER as expected.
Next, we performed DNA microarray analyses with total
RNA isolated from these cells and the GeneChip® Mouse
Genome 430 2.0 Array from Affymetrix (Santa Clara, CA)
according to manufacturer's instructions. We set the crite-
ria for genes of significance to be those whose expression
is down regulated at least 2-fold by Id1 and reverted over
2-fold by E47-ER, or vice versa. Furthermore, the expres-
sion level of these genes must be at least 2-fold higher
than background and receive a "present call" determined
by the computer program designed by Affymetrix. Thus,
we obtained 438 genes down-regulated by Id1 compared
to vector-transduced cells. Out of these genes, 203 genes
were activated by E47-ER after induction with 4-OHT for
one hour. Table 1 lists the first 25 genes whose expression
is most dramatically reduced by Id1. Topping this list is
the RORγ gene, which was down-regulated 44-fold by Id1
and re-activated 22-fold by E47-ER. However, a large frac-
tion of genes on this list have unknown function. There-
fore, their relevance to T cell development was not
immediately apparent. Despite this, several genes previ-
ously known to be regulated by E2A are among the group
of 203 identified, which provided us with confidence in
the procedure. For example, the Cdkn1a (p21) gene was
down and up-regulated by about 5-fold, respectively,
whereas expression of CD4 and RAG1 or 2 genes was
altered by 2–3 fold [29-31].
In contrast, we found 1547 genes to be up-regulated by
Id1, of which only 253 genes were repressed by E47-ER
within 1 hour. Since Id1 is known to be an inhibitor of
E2A transcription activators, it is reasonable that a smaller
percentage of the up-regulated genes are direct conse-
quences of loss of E protein function. Rather, expression
of the majority of the genes may be indirectly influenced
by cellular conditions altered by Id1 expression. For exam-
ple, of the first 25 genes whose expression was up-regu-
lated by Id1, only 7 of them were repressed by E47-ER
(Table 1). This compared to 24 of the 25 genes, which
were down-regulated by Id1 and re-activated by E47-ER.
However, it will be interesting to further verify if the 253
genes are directly repressed by E2A. As expected, Id1 itself
Table 1: Genes regulated by Id1 and E47-ER
Accession 
number
Fold ↓ by Id1 Fold ↑ by E47ER Genes Accession 
number
Fold ↑ by Id1 Fold ↓ by E47ER Genes
AF163668 44.22 21.82 RORc# U43884 857.89 0.49 Idb1
BB391602 42.06 14.56 EST BB703880 137.38 2.09 EST
AW492576 35.85 23.38 EST X03802 91.66 0.54
AK020348 33.65 34.20 Acbd7 BB199001 84.05 0.54
BB204492 33.38 32.92 EST BG070914 43.65 1.59
BB702377 31.11 3.96 EST NM_011395 42.49 1.56
NM_008179 25.27 16.41 Gspt2 BF456582 38.25 2.22 EST
BE981638 24.18 14.79 EST BC021939 36.72 2.78 osteoglycin
BM239905 23.17 25.83 EST C79967 36.43 1.05
BB045044 23.15 4.44 EST AB013605 35.39 29.63 Per3
AV341285 22.55 5.38 EST BB364262 34.29 1.55
BB780056 21.67 17.51 EST AV354897 33.43 17.12 EST
BI732921 19.50 8.13 EST BB206037 32.75 1.58
BG071830 18.46 1.37 BB283894 31.92 0.92
BB748702 16.95 1.97 BB217381 31.18 1.91
AK008128 16.87 2.11 Unknown* AU080926 30.46 0.72
NM_025422 16.78 7.84 CD302 BB023986 28.53 1.24
BC021465 16.77 6.08 unknown BB346879 27.46 0.97
BG065821 15.67 6.42 EST BB005315 27.24 0.90
AV013697 15.56 8.41 EST AK021082 25.85 7.48 unknown
BE956696 15.51 11.60 EST AU022985 24.86 10.15 EST
BB375478 15.00 10.40 EST BE649198 23.98 0.95
BM245920 14.90 6.69 EST AK017568 23.70 1.27
BB366565 14.83 21.44 EST NM_007518 23.48 1.86
AV303905 14.53 14.12 EST AF054581 22.37 1.39
# also known as RORγ; * cDNA with unknown function.BMC Immunology 2008, 9:20 http://www.biomedcentral.com/1471-2172/9/20
Page 5 of 11
(page number not for citation purposes)
was found to be the gene expressed at the highest level
(858 fold) but was not repressed by E47-ER, further vali-
dating our experimental procedures.
RORγ is a direct target gene of E2A
The RORγ gene encodes two transcripts, RORγ and RORγt
[23,32]. RORγt is specifically expressed in T cells from an
internal promoter located between exons 1 and 2 of the
gene. Using primers specific for RORγ and RORγt tran-
scripts, we found by RT-PCR that RORγt but not RORγ was
expressed in 16610D9 cells. Real-time PCR assays con-
firmed that RORγt expression was diminished in Id1
expressing cells by 23 fold, compared to cells transduced
with vector control (Fig. 2A). To test if Id1 expression in
primary thymocytes inhibits RORγt expression, we trans-
duced wild-type thymocytes with vector or Id1-expressing
retroviruses, sorted transduced cells based on GFP expres-
sion and measured RORγt levels using RT-PCR. Indeed,
RORγt levels were significantly reduced by Id1 (Fig. 2B).
Together, these results confirmed that RORγt expression
could be inhibited by Id1.
To further verify if RORγt is indeed a target gene of E pro-
teins, we tested if E2A is bound to the promoter region of
the RORγt using chromatin immunoprecipitation assays
(Fig. 3). Several E boxes, to which E proteins bind, were
found near the RORγt promoter region (Fig. 3A). We used
E47-ER expressing 16610D9 cells or primary DP thymo-
cytes for these assays. PCR products containing the two
proximal E boxes were detected (by amplifying with
primer pairs 1–2 and 3–4) in the anti-E2A immunopre-
cipitates from 16610D9 cells treated with or without 4-
OHT (Fig. 3B). In contrast, anti-ER antibodies only
brought down these fragments from 16610D9 cells
induced with 4-OHT, which demonstrated the specificity
of the assay. Furthermore, control antibodies against an
irrelevant protein did not precipitate any DNA in this
region. The distal E boxes included in the fragment ampli-
fied by primers 5 and 6 were only brought down when
E47-ER was induced, suggesting that these E boxes are
unlikely to be bound with physiological levels of E pro-
teins. From primary DP thymocytes, anti-E2A but not
anti-ER antibodies pulled down DNA containing the two
proximal E boxes but not the distal ones, demonstrating
the specific binding by endogenous E2A proteins (Fig.
3B). Collectively, these data suggest that RORγt is likely a
direct target of E proteins in vivo.
Effects of RORγt on Id1-induced apoptosis
It has previously been shown that Id1 expression causes
massive apoptosis of developing thymocytes [18,20].
Because RORγt has been implicated in protection of dou-
ble positive thymocytes from apoptosis, we examined the
effect of RORγt on Id1-induced apoptosis of 16610D9
cells [25]. We transduced the cells with retroviruses
expressing Id1 or RORγt individually or together. Trans-
duced cells were sorted based on GFP or YFP expression
and cultured for 6 days. Cells were then stained with PE-
conjugated Annexin-V and 7AAD. Annexin-V positive and
7AAD negative cells were considered apoptotic cells.
Expression of Id1 in 16610D9 cells resulted in about 34%
Annexin-V positive cells, whereas the percentages in vec-
tor or RORγt transduced cells were only about 20% (Fig.
4A). Co-expression of Id1 with RORγt reduced the per-
centage of apoptotic cells back down to 19%. These exper-
iments were repeated multiple times and the averages of
Annexin-V positive cells are shown in Fig. 4B. As controls,
Regulation of RORγt expression by Id1 and E47 Figure 2
Regulation of RORγt expression by Id1 and E47. (A) 
Real-time reverse transcriptase-PCR assays were performed 
using RORγt or β-actin specific primer sets on cDNA sam-
ples from vector or Id1 transduced 16610D9 cells. The 
primer sequences for RORγt are GTGTGCTGTCCT-
GGGCTACC and AGCCCTTGCACCCCTCACAG. Those 
for β-actin are GGCTGTATTCCCCT CCATCG and 
CCAGTTGGTAACAATGCCATGT. The Ct values of 
RORγt were normalized against those of β-actin. Data are 
presented relative to the normalized RORγt level in Id1 
expressing cells, with standard deviations obtained from at 
least three data points for each sample. (B) RT-PCR assays 
were conducted on serially diluted cDNA samples of primary 
thymocytes transduced with vector or Id1-expressing retro-
viruses.
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we stained cells cultured one day after sorting and found
no significant difference in percentages of apoptotic cells
(Fig. 4B). These results suggest that reduction in RORγt
expression is a potential cause for apoptosis occurring in
Id1-expressing cells.
RORγt selectively prevents Id1-induced p38 MAP kinase 
hyper-activation
p38 MAP kinase is often activated in cells under stress or
undergoing apoptosis [33,34]. Therefore, we measured
p38 activation in Id1 and/or RORγt expressing 16610D9
cells. Since T cell receptor (TCR) signaling is known to
influence MAP kinase activities [35], we also examined
MAP kinase activation following TCR signaling triggered
by incubation with anti-CD3 antibodies. Even in the
absence of anti-CD3, the level of phospo-p38 (pp38) was
dramatically increased by Id1 but not by RORγt. RORγt
appeared to decrease the level of pp38 compared to vector
control but this became insignificant when normalized
against total amounts of p38 in each lane. However, co-
expression of Id1 with RORγt abolished the positive effect
of Id1 on p38 activation before and after anti-CD3 stimu-
lation (Fig. 5A). This effect of RORγt is consistent with its
anti-apoptotic function shown in Fig. 4. However,
whether p38 activation is directly regulated by RORγt or
indirectly influenced by the overall cellular condition
remains to be investigated.
In contrast to p38 activation, Erk1 and 2 were phosphor-
ylated immediately following TCR signaling. TCR-
induced activation of Erk1 and 2 was potentiated by Id1
expression, although basal levels of Erk1 and 2 present in
E2A binds near the RORγt promoter region Figure 3
E2A binds near the RORγt promoter region. (A) Schematic representation of the RORγt gene. Exon1 is shown as a 
white box with transcription start site marked by an arrow and the ATG codon labeled. Dark boxes represent E boxes 
(RCAGNTG) and their location is denoted by the number of nucleotides relative to the transcription start site. Small arrows 
signify primers used for PCR. (B) Chromatin immunoprecipitation assays with indicated antibodies and primer sets. Control 
(CTR) antibodies used were anti-CD3 antibodies. E47-ER transduced 16610D9 cells treated with or without 4-OHT and DP 
thymocytes were used in the assays. PCR performed with 2% of total input DNA served as controls.
Input
IP
P1+P2
(130 bp)
-- -  +       +        +
CTR -E2A   -ER
4-OHT
CTR -E2A   -ER
Input
IP
P3+P4
(130 bp)
Input
IP
P5+P6
(220 bp)
Primers:
ATG
Exon 1
P1 P3
P2 P4
P5
P6
113 -6 590 926 900 889 799
CTR -E2A     -ER
DP thymocytes E47ER-infected 16610D9 cells
A.
B.BMC Immunology 2008, 9:20 http://www.biomedcentral.com/1471-2172/9/20
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RORγt rescues Id1-induced apoptosis Figure 4
RORγt rescues Id1-induced apoptosis. (A) Annexin V staining. 16610D9 cells were transduced with indicated retroviruses 
and sorted based on GFP or YFP expression from the RORγt and Id1 retrovectors, respectively. Sorted cells were cultured for 
6 days before the analysis. Cells negative for 7-AAD staining were scored for Annexin-V binding by percentage. (B) Average 
percentages of Annexin-V positive cells were obtained from three independent experiments. Data obtained on Day 6 are 
shown in dark bars and those on Day 1 are presented in gray and serve as negative controls. Error bar shows standard devia-
tion.
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the absence of TCR stimulation were not affected. How-
ever, RORγt had no effect on Erk activation in the absence
or presence of Id1 (Fig. 5A). Therefore, these results pro-
vided supporting evidence that RORγt specifically coun-
teracts Id1-induced p38 activation. Id1 expression did not
alter JNK activities with or without TCR stimulation (data
not shown). Therefore, the effect of RORγt on JNK was not
examined.
Consistent with our findings in 16610D9 T cells, we have
also detected elevated levels of phospho-p38 in double
positive thymocytes freshly isolated from Id1 transgenic
mice (Fig. 5B). Likewise, levels of activated Erk were also
increased in these cells. Thus, these data indicate that Id1
expression alters MAP kinase signaling not only in T cell
lines but also in thymocytes of transgenic mice.
Discussion
We have presented data to suggest that the RORγ gene is a
direct target of E2A transcription factors, whose function
can be inhibited by Id1 and loss of RORγt expression
could, at least in part, account for the pro-apoptotic effect
of Id1. These data are consistent with those noted by oth-
ers including the finding that thymocytes of transgenic
mice expressing SCL/Tal1, another inhibitor of E proteins,
have reduced expression of RORγ [26,36]. Expression of
Id1 in transgenic mice not only blocks T cell differentia-
tion but also causes massive apoptosis [18]. Examination
of the apoptotic cells reveals that these cells have function-
RORγt prevents Id1-induced p38 hyper-activation Figure 5
RORγt prevents Id1-induced p38 hyper-activation. (A) Immunoblot analyses of MAP kinase activation in the absence or 
presence of TCR signaling. 16610D9 cells were transduced with indicated retroviruses and stimulated with soluble anti-CD3 
antibodies plus protein A-streptavidin for indicated lengths of time. Whole cell lysates were used for immunoblotting with anti-
bodies against indicated proteins. (B) Immunoblot analysis of MAP kinase activation in sorted DP thymocytes.
0    2   10   30 0    2    10   30 0    2   10   30 0    2    10   30
pp38
D -CD3(min)
Vector RORJt Id1 Id1/RORJt
p38
FLAG- 
RORJt
HA-Id1
pERK1/2
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ally rearranged TCRβ genes and are likely double positive
thymocytes [20]. Interestingly, RORγ deficient mice also
display similar phenotypes characterized by reduced
numbers of DP thymocytes and massive apoptosis in the
thymus [24,25]. These similarities, together with the fact
that RORγt rescues Id1-induced cell death in 16610D9
cells, lend support to the notion that reduction in RORγt
expression due to inhibition of E protein function may
contribute to apoptosis of developing thymocytes in Id1
transgenic thymuses. However, this may not be the only
reason, because the apoptotic phenotype of RORγ defi-
cient mice can be rescued by transgenic expression of Bcl-
xL [25] whereas expression of Bcl2 does not protect Id1
transgenic thymocytes (data not shown). Although Bcl-xL
is thought to be a target of RORγt [25], we could not eval-
uate the effect of Id1 on its expression because 16610D9
cells produce very low levels of Bcl-xL.
RORγt has also been shown to be able to suppress cell pro-
liferation [26,37]. Because precursor T cells undergo tre-
mendous expansion during their differentiation, levels of
RORγt must be carefully modulated to maintain a balance
between proliferation and survival. Interestingly, the func-
tion of E proteins, which are known to inhibit cell cycle
[8], is also temporally controlled in this process. Namely,
Id3 gene expression is transiently activated following pre-
TCR signaling via the Ras-MAP kinase pathway, leading to
inhibition of DNA binding by E proteins [15]. Conse-
quently, loss of E protein function may result in reduced
RORγt expression, thus allowing cell proliferation to pro-
ceed. When Id3 expression decreases and E protein func-
tion recovers, RORγt expression returns to suppress cell
cycle progression and facilitate the survival of DP thymo-
cytes. Because of the growth suppressive function of
RORγt, its overexpression under the CD2 promoter
resulted in dramatically reduced cellularity in transgenic
mice [37]. The CD4 promoter drives RORγt expression in
a fraction of DP thymocytes of transgenic mice [38]. How-
ever, when these mice were crossed with Id1 transgenic
mice, RORγt-expressing cells as indicated by the fluores-
cence of GFP co-expressed from the same transgenic con-
struct were drastically under-represented (Yang and Sun,
data not shown). It is not clear if this is due to inhibition
of the CD4 promoter by Id1 or selective elimination of
RORγt expressing cells by Id1. Nevertheless, these compli-
cations prevented us from determining if RORγt could res-
cue cell death and influence T cell development or
tumorigenesis in animals.
We have shown that both Erk and p38 MAP kinases are
hyper-activated in DP cells of Id1 transgenic mice, which
may have profound effects on developing thymocytes,
leading to their death. It is interesting that RORγt expres-
sion in 16610D9 cells could prevent Id1-induced hyper-
activation of the p38 MAP kinase. This may be an indica-
tion of the protective effect of RORγt on Id1-expressing
16610D9 cells since we have found that apoptosis as
measured by Annexin-V staining is alleviated by RORγt.
Alternatively, p38 activation may play an active role in
triggering cell stress responses and apoptosis. RORγt may
act by inhibiting p38 activation and protecting cells from
apoptosis. In contrast to p38, Erk hyper-activation follow-
ing TCR signaling is not suppressed by RORγt, which sug-
gests that Id1 affects Erk and p38 through different
mechanisms. It is possible that Erk activation depends on
TCR signaling and Id1 expression influences the signaling
pathway through an unknown mode of action. This is
consistent with our previous findings that Id1 lowers the
threshold of pre-TCR or TCR signaling and alters the out-
come of T cell selection processes [19,20]. On the other
hand, Id1 expression may also affect cell survival proc-
esses that are downstream or independent of TCR signal-
ing by inhibiting RORγt expression. The fact that Id1 is
specifically turned on during negative but not positive
selection suggests that Id1 might play a role in eliminating
self-reacting thymocytes [17]. Taken together, these obser-
vations illustrate the complexity of coordinated molecular
events that ensure proper development of T lymphocytes.
E proteins act as important regulators of T cell differentia-
tion by controlling multiple crucial checkpoints in the
process, perhaps by regulating transcription of many dif-
ferent genes. Our microarray analyses revealed RORγt as a
strong candidate to be positively controlled by E proteins.
Several additional candidates scored comparably to
RORγt but their functions are unknown or their connec-
tions with T cell biology are not apparent. Future investi-
gation might uncover novel links between these other
genes controlled by E proteins and provide a more com-
plete description of the function of E proteins in T cell
development.
Conclusion
This study highlights the link between E protein control-
led RORγt expression and apoptosis of Id1-expressing T
cells. Because Id1 is a natural inhibitor of E proteins and
is specifically turned on during negative selection of T
cells, findings described here will likely be of physiologi-
cal significance and shed light on mechanisms regulating
T cell maturation.
Methods
Cell culture and retroviral transduction
The retroviral construct expressing Id1 is as described
except that EGFP was replaced with YFP [27]. To express
E47-ER, an EcoRI fragment containing the coding
sequence of human E47 without the stop codon was fused
with another EcoRI fragment encoding the modified hor-
mone-binding domain of estrogen receptor, which prefer-
entially binds tamoxifen [28]. Both EcoRI fragments wereBMC Immunology 2008, 9:20 http://www.biomedcentral.com/1471-2172/9/20
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cloned into the EcoRI site of the MIGR1 vector that also
expresses EGFP from an internal ribosome entry site [39].
For the RORγt expression vector, a BamHI-EcoRI fragment
generated by RT-PCR with 5' (GGATCCatgagaacacaaattg
aagtgatc) and 3' (GAATCCTCACTTTGACAGCCCCT-
CAGG) primers was cloned into Bgl II-EcoRI site of
MIGR1 with a HPC4 tag at the 5' end.
Retroviruses were produced by transient transfection of
the Phoenix-E packaging cell line [40]. Culture superna-
tants were collected and spin-infection of 16610D9 cells
was carried out by centrifuging the cells in viral superna-
tants for two hours in the presence of 4 µg/ml polybrene
followed by incubation at 37°C for an additional two
hours. Cells were then cultured in fresh medium at 37°C
for 20 hours before sorting. To transduce primary thymo-
cytes, thymocytes isolated from wild type mice were
mixed with viral supernatants containing 4 µg/ml poly-
brene and incubated at 25°C for 30 min before spin-infec-
tion. Transduced cells were sorted using Moflo (Dako,
Denmark) with the capability to separate GFP and YFP-
expressing cells. Sorted GFP and/or YFP positive cells were
cultured overnight at 37°C before treatment with 1 µM 4-
OH-tamoxifen.
Microarray analysis
Total RNA was extracted using TRIzol reagent (Invitrogen)
and further purified with RNeasy kit (Qiagen, Valencia,
CA). Target probes for microarray analysis were prepared
as described in the Affymetrix GeneChip Expression Anal-
ysis Manual. Briefly, 5 µg of total RNA was reverse tran-
scribed and double-stranded cDNAs were synthesized
with the Superscript II cDNA System (Invitrogen,
Carlsbad, CA) using T7-Oligo(dT)24 primer. Double-
stranded cDNA was purified using the GeneChip Samples
Cleanup Module (Affymetrix, Santa Clara, CA) and used
for synthesis of biotin-labeled antisense cRNA with BioAr-
ray High Yield RNA Transcript Labeling IVT Kit (Affyme-
trix). cRNA was purified using GeneChip Sample Cleanup
Module for IVT cRNA (Affymetrix). Twenty µg of cRNA
was fragmented in 1× fragmentation buffer (40 mM Tris-
acetate (pH 8.1), 100 mM KOAc, 30 mM MgOAc) for 35
min at 94°C. Eighteen µg of the fragmented cRNA was
used to hybridize with Affymetrix Genechip Mouse
Genome 430 2.0 chips for 16 h at 45°C in an Affymetrix
Hybridization Oven 640 while rotating at a speed of 60
rpm. The chips were washed and stained with R-Phyco-
erythrin Streptavidin in Affymetrix Fluidics Station 450
according to an Affymetrix GeneChip protocol and
scanned using an Affymetrix GeneChip Scanner 3000. The
preliminary data were analyzed using Affymetrix Microar-
ray Suite 5.0 and exported to Microsoft Excel for further
analysis.
Chromatin immunoprecipitation assays
ChIP assays were performed using ChIP assay kit (Milli-
pore, Billerica, MA) according to manufacturer's instruc-
tions. 1 × 107 cells were fixed and lysed in lysis buffer in
the presence of protease inhibitors. Lysate was sonicated
to shear DNA into 300–500 bp fragments and immuno-
precipitated with antibodies against E47 or estrogen
receptor (ER) (Santa Cruz Biotechnology, Santa Cruz, CA)
as well as CD3 (BD Pharmingen, San Diego, CA). Immu-
noprecipitated DNA was recovered by proteinase K diges-
tion and used for PCR amplification for 30 or 33 cycles
along with input DNA (2%) as controls. PCR products
were resolved using 2% agarose gel. Primers used for PCR
are P1, GTGCCTGTCATCATACC CAATGC; P2, gtgcct-
cagcccttagatctgcac; P3 GTGCAGATCTA AGGGCTGAGGC;
P4 CATTCACTTACTTCTCATGACTG; p5 GACTGCTC
TGTGTGTGCTATGTG and p6 GCTTCCCTTACATGAG-
CAGGGAGGATC.
Immunoblotting
Sorted primary thymocytes or 16610D9 cells with or with-
out stimulation were lysed in radioimmuno-precipitation
buffer (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4,
1.4 mM KH2PO4, 1% Nonidet P-40, 0.5% sodium deoxy-
cholate, and 0.1% SDS) plus cocktails of protease and
phosphatase inhibitors, and supernatants were collected
after centrifugation. Protein concentrations were deter-
mined by using the BCA reagents (Pierce, Rockford, IL).
Thirty micrograms of each protein extract was analyzed
using SDS-polyacrylamide gels. Antibodies specific for
p38, phospho-p38, ERK1, and phospho-ERK1/2 were
purchased from Cell Signaling Technology (Beverly, MA);
anti-Flag and anti-HA antibodies were from Sigma (St.
Louis, MO).
Apoptosis assay
Retrovirally transduced cells were sorted and cultured for
6 days. Cells were then washed with 2× PBS and stained
with Annexin V-PE together with 7-AAD (7-Amino-Actin-
omycin D) for 15 minutes at room temperature in the
dark as suggested by the manufacturer (BD Pharmingen).
Stained Cells were analyzed using flow cytometry on LSR
II (BD Pharmingen), apoptotic cells were defined as
Annexin-PE positive and 7-AAD negative.
Abbreviations
DN: double negative; DP: double positive; SP: single pos-
itive; RORγ: retinoid-related orphan receptor gamma; Id:
inhibitor of differentiation
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